Validation of the imatinib-therapy failure model

Leukemia. 2023 May;37(5):1166-1169. doi: 10.1038/s41375-023-01875-3. Epub 2023 Mar 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Humans
  • Imatinib Mesylate / therapeutic use
  • Pyrimidines / therapeutic use

Substances

  • Imatinib Mesylate
  • Antineoplastic Agents
  • Pyrimidines